Summary:
Ovarian function and sex hormone production with special focus on androgens (testosterone, androstenedione, dehydroepiandrosterone and its sulfate, DHEAS) was followed up during 1.5–20 (mean 9) years after bone marrow transplantation (BMT) in 24 female subjects aged 16–33 (mean 21) years at the last follow-up. All patients had received TBI and high-dose chemotherapy as the preparative regimen. A total of 24 female patients with conventionally treated pediatric hematologic malignancies served as controls. Four of 24 transplanted patients had spontaneous menstruation several years post transplantation, but in only one of them were serum FSH levels normal. Androgen levels of the BMT patients were lower than those of the conventionally treated patients. Subnormal testosterone levels were observed in 43% of BMT patients and subnormal DHEAS levels in 34% of BMT patients, the latter being a constant finding during glucocorticoid therapy for chronic GVHD (cGVHD). These results indicate that ovarian damage is a common late effect in patients transplanted at a young age, still having a seemingly normal pubertal development. Ovarian damage and cGVHD with glucocorticoid therapy are strongly associated with subnormal androgen levels. The clinical consequences of these changes and possible benefits of putative androgen replacement therapy remain to be elucidated.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Matsumoto M, Shinohara O, Ishiguro H et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child 1999; 80: 452–454.
Sarafoglou K, Boulad F, Gillio A, Sklar C . Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997; 130: 210–216.
Sanders JE, Hawley J, Levy W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045–3052.
Spinelli S, Chiodi S, Bacigalupo A et al. Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: long-term follow-up of 79 females. Bone Marrow Transplant 1994; 14: 373–380.
Watson M, Wheatley K, Harrison GA et al. Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial. Cancer 1999; 86: 1231–1239.
Arlt W, Callies F, van Vlijmen JC et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999; 341: 1013–1020.
Labric F, Diamond P, Cusan L et al. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 1997; 82: 3498–3505.
Morales AJ, Haubrich RH, Hwang JY et al. The effect of six months treatment with a 100 mg daily dose of dehydroepianrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxford) 1998; 49: 421–432.
Hovi L, Tapanainen P, Saarinen-Pihkala UM, Siimes MA . Impaired androgen production in female adolescents and young adults after total body irradiation prior to BMT in childhood. Bone Marrow Transplant 1997; 20: 561–565.
Gustafsson G, Kreuger A, Clausen N et al. Intensified treatment of acute lymphoblastic leukemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Acta Paediatr 1998; 87: 1151–1161.
Lie SO, Jonmundsson G, Mellander L et al. A population-based study of 272 children with acute myeloid leukemia treated on two consecutive protocols with different intensity: best outcome in girls, infants and children with Down's syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Br J Haematol 1996; 94: 82–88.
Apter D . Serum steroids and pituitary hormones in female puberty: a partly longitudinal study. Clin Endocrinol 1980; 12: 107–120.
Lashansky G, Saenger P, Fishman K et al. Normative data for adrenal steroidogenesis in a healthy pediatric population: age- and sex-related changes after adrenocorticotropin stimulation. J Clin Endocrinol Metab 1991; 73: 674–686.
Sanders JE, Buckner CD, Amos D et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 1988; 6: 813–818.
Thomas BC, Stanhope R, Plowman PN, Leiper AD . Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood. Acta Endocrinol 1993; 128: 508–512.
Byrne J, Fears TR, Gail MH et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992; 166: 788–793.
Hinterberger-Fischer M, Kier P, Kalhs P et al. Fertility, pregnancies and offspring complications after bone marrow transplantation. Bone Marrow Transplant 1991; 7: 5–9.
Kauppila M, Koskinen P, Irjala K et al. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults. Bone Marrow Transplant 1998; 22: 331–337.
Oelkers W . Dehydroepiandrosterone for adrenal insufficiency. N Engl J Med 1999; 341: 1073–1074, (edit.).
Nysom K, Holm K, Fleischer Michaelsen K et al. Bone mass after allogeneic BMT for childhood leukemia or lymphoma. Bone Marrow Transplant 2000; 25: 191–196.
Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M . Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 2000; 356: 993–997.
Shifren J, Braunsteig G, Simon J et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343: 682–688.
Acknowledgements
This study was supported by a grant from the Foundation of Nona and Kullervo Väre.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hovi, L., Saarinen-Pihkala, U., Taskinen, M. et al. Subnormal androgen levels in young female bone marrow transplant recipients with ovarian dysfunction, chronic GVHD and receiving glucocorticoid therapy. Bone Marrow Transplant 33, 503–508 (2004). https://doi.org/10.1038/sj.bmt.1704376
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704376
Keywords
This article is cited by
-
Prediction Potency of Gonadal Hormone Alterations on Sexual Dysfunction After Hematopoietic Stem Cell Transplantation
Reproductive Sciences (2021)
-
Androgens in women after allogeneic hematopoietic cell transplantation: impact of chronic GvHD and glucocorticoid therapy
Bone Marrow Transplantation (2017)
-
Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding
International Journal of Hematology (2016)